Sandbox Reserved 1095: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
=== Primary and secondary structure === | === Primary and secondary structure === | ||
Human angiotensin receptor consists in a 376 amino acid string <ref> http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/GetPage.pl </ref>. The protein is composed of | Human angiotensin receptor consists in a 376 amino acid string <ref> http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/GetPage.pl </ref>. The protein is composed of <scene name='82/829348/Helix_a_and_b_sheet/1'> 18 alpha helix</scene> and <scene name='82/829348/Helix_a_and_b_sheet/1'> 3 beta sheets</scene>. Moreover, 7 alpha helix are made of a majority of hydrophobic amino acids. These helix are long enough to cross the membrane and create an <scene name='82/829348/Transmambrane_protein/1'>hydrophobic domain</scene> which is situated into the membrane. The human angiotensin receptor is therefore an alpha helical trans-membrane protein. | ||
Since the angiotensin receptor belongs to the GPCRs family, those 7 alpha helix contain 3 extracellular and 3 intracellular loops. | |||
=== Ligand binding pocket === | === Ligand binding pocket === | ||
| Line 42: | Line 43: | ||
=== Interaction with other GPCRs === | === Interaction with other GPCRs === | ||
It has been | It has been discovered that AT1Rs were also able to bind with other GPCRs to form homo- or heterodimers. Those interactions can modify the sensitivity of the receptor, which leads to different physiological and pathological conditions than the GPCR monomer <ref> http://www.jbc.org/content/290/49/29127 </ref> <ref>https://doi.org/10.1016/j.phrs.2017.06.013 </ref>. The most known heterodimers including AT1 receptor are with ß2-adrenergic receptor, the apelin receptor, and AT2 receptor. Those interactions could be facilitated by several transmembrane domains. | ||
The oligomeric complexes' formation complicates the understanding of AT1R pharmacology. | |||
== Application in the therapeutic field == | == Application in the therapeutic field == | ||